SVLC Portfolio in the News

GEn1E Lifesciences Announces Partnership with BARDA to Advance its AI-powered Endotyping Program for ARDS Patients to Further Accelerate its Novel, Lead Compound GEn-1124

Daniela Guerra 10/26/23 Daniela Guerra 10/26/23

GEn1E Lifesciences Announces Partnership with BARDA to Advance its AI-powered Endotyping Program for ARDS Patients to Further Accelerate its Novel, Lead Compound GEn-1124

Oct. 24, 2023

Read More

GEn1E Lifesciences Adds NextGen Selective Immunomodulator Target to Portfolio, Broadens Pipeline

Guest User 8/8/23 Guest User 8/8/23

GEn1E Lifesciences Adds NextGen Selective Immunomodulator Target to Portfolio, Broadens Pipeline

July 21, 2023

Read More

Report of the first seven agents in the I-SPY COVID trial: a phase 2

Guest User 3/2/23 Guest User 3/2/23

Report of the first seven agents in the I-SPY COVID trial: a phase 2

March 2, 2023

Read More

Winners of the 4th Annual UCSF | Health Hub: Digital Health Awards Announced

Guest User 11/29/22 Guest User 11/29/22

Winners of the 4th Annual UCSF | Health Hub: Digital Health Awards Announced

November 21, 2022

Read More

Full-dose anticoagulation treatment prevented blood clots in COVID-19 patients

Guest User 8/29/22 Guest User 8/29/22

Full-dose anticoagulation treatment prevented blood clots in COVID-19 patients

August 29, 2023

Read More

UMB, in partnership with alumni, wants to commercialize rare disease treatments

Guest User 8/3/22 Guest User 8/3/22

UMB, in partnership with alumni, wants to commercialize rare disease treatments

August 3, 2022

Read More

GEn1E Lifesciences Adds NextGen Selective Immunomodulator

Guest User 7/26/22 Guest User 7/26/22

GEn1E Lifesciences Adds NextGen Selective Immunomodulator

July 26, 2022

Read More

Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force

Guest User 3/18/20 Guest User 3/18/20

Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force

March 18, 2020

Read More